Cargando…
Patent cliff and strategic switch: exploring strategic design possibilities in the pharmaceutical industry
Extending the period of the market exclusivity and responding properly to the recent agglomeration of patent expiries are pivotal to the success of pharmaceutical companies. Declining R&D productivity, rising costs of commercialization, near-term patent expirations for many top-selling drugs are...
Autores principales: | Song, Chie Hoon, Han, Jeung-Whan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4899342/ https://www.ncbi.nlm.nih.gov/pubmed/27347468 http://dx.doi.org/10.1186/s40064-016-2323-1 |
Ejemplares similares
-
Strategic Patenting by Pharmaceutical Companies – Should Competition Law Intervene?
por: Gurgula, Olga
Publicado: (2020) -
Strategic Management for the Plastics Industry
por: Jones, Roger
Publicado: (2016) -
Strategic Choices in Converging Industries
por: Van Alstyne, Marshall
Publicado: (2013) -
Strategic Possibility Routes of Recycled PET
por: Damayanti,, et al.
Publicado: (2021) -
Strategic modulation of response inhibition in task-switching
por: Grzyb, Kai Robin, et al.
Publicado: (2013)